Article 4219

Title of the article

THE INFLUENCE OF THE ENDOVASCULAR INTERVENTION TIMING ON THE POST-INFARCTION PERIOD 

Authors

Lukyanova Marina Vladimirovna, Candidate of medical sciences, associate professor, sub-department of therapeutics, Medical Institute, Penza State University (40 Krasnaya street, Penza, Russia), E-mail: mavlu2002@gmail.com
Dushina Elena Vladimirovna, Assistant, sub-department of therapeutics, Medical Institute, Penza State University (40 Krasnaya street, Penza, Russia), E-mail: dushina-elena@bk.ru
Barmenkova Yulia Andreevna, Assistant, sub-department of therapeutics, Medical Institute, Penza State University (40 Krasnaya street, Penza, Russia), E-mail: yulenka.gsk@gmail.com
Oreshkina Anastasia Aleksandrovna, Student, Medical Institute, Penza State University (40 Krasnaya street, Penza, Russia), E-mail: anast.oreschckina@yandex.ru 

Index UDK

616.127-005.8 

DOI

10.21685/2072-3032-2019-2-4 

Abstract

Purpose. The aim of the study was to evaluate the impact of the percutaneous coronary intervention (PCI) timing on the post-infarction period in patients after myocardial infarction with ST-segment elevation (STEMI).
Materials and methods. The objects of study were 58 patients with STEMI, aged 50,8 ± 8,5 years. All patients underwent multidirectional diagnosis of the postinfarction period: evaluation of quality of life using the Seattle Angina Questionnaire (SAQ) questionnaire, laboratory diagnosis of chronic heart failure (CHF) using the analysis of brain natriuretic peptide (BNP), Holter ECG monitoring (Holter ECG) for the diagnosis of rhythm disorders and episodes of myocardial ischemia.
Results. The quality of life of patients significantly improved by the 12th week by 17 % (p = 0,0004) and 15,3 % (p = 0.004) in both groups according to the SAQ questionnaire. BNP level analysis confirmed the positive dynamics of recovery in the early revascularization group and amounted to 90,6 pg / ml (p = 0,02) by the 24th week of follow-up. Episodes of myocardial ischemia (42,5 %) and the development of life-threatening arrhythmias (42,5 %) according to the Holter ECG were recorded in the group of late revascularization much more often (p = 0,03 and p = 0,005, respectively).
Conclusion. A reduction in the timing of revascularization in patients with STEMI contributes to a more rapid recovery of contractile myocardium and significantly improves the quality of life of patients in the post-infarction period. 

Key words

myocardial infarction, percutaneous coronary intervention, quality of life, Holter ECG monitoring 

Download PDF
References

1. Eur. Heart. J. 2018, vol. 39 (2), pp. 119–177.
2. Ioseliani D. G., Kostyanov I. Yu., Vasil'ev P. S., Koledinskiy A. G., Gromov D. G., Koval'chuk I. A., Sukhorukov O. E., Matini M. B., Baratashvili V. L. Interventsionnaya kardiologiya [Cardiological intervention]. 2013, no. 33, pp. 22–33. [In Russian]
3. Khubutiya M. Sh., Gazaryan G. A., Zakharov I. V. Reperfuzionnaya terapiya v ostrom periode infarkta miokarda [ ]. Moscow: GEOTAR-Media, 2010, p. 168. [In Russian]
4. Fokkema M. L., James S. K., Albertsson P., Akerblom A., Calais F., Eriksson P., Jensen J., Nilsson T., Smet B. J., Sjögren I., Thorvinger B., Lagerqvist B. J. Am. Coll. Cardiol. 2013, no. 61 (12), pp. 1222–1230.
5. Madan M., Halvorsen S., Mario C., Tan M., Westerhout C. M., Cantor W. J., Le May M. R., Borgia F., Piscione F., Scheller B., Armstrong P. W., Fernandez-Aviles F., Sanchez P. L., Graham J. J., Yan A. T., Goodman S. G. JACC Cardiovasc Interv. 2015, no. 8, pp. 166–174.
6. Menon V., Pearte C. A., Buller C. E., Steg P. G., Forman S. A., White H. D., Marino P. N., Katritsis D. G., Caramori P., Lasevitch R., Loboz-Grudzien K., Zurakowski A., Lamas G. A., Hochman J. S. European Heart Journal. 2009, no. 30 (2), pp. 183–191.
7. Sokolov Yu. N., Sokolov M. Yu., Terent'ev V. G., Tarapon I. V., Kobylyak V. Yu., Sirenko A. Yu., Levchuk N. P., Krot E. N. Ukrainskiy kardiologicheskiy zhurnal [Ukrainian cardiological journal]. 2015, no. 1, pp. 15–25.
8. Spertus J. A., Winder J. A., Dewhurst T. A., Deyo R. J Am Coll Cardiol. 1995, no. 25 (2), pp. 333–341.
9. Lang T. A., Sesik M. Kak opisyvat' statistiku v meditsine. Rukovodstvo dlya avtorov, redaktorov i retsenzentov [How to describe statistics in medicine. Handbook for authors, editors and reviewers]. Moscow: Prakticheskaya Meditsina, 2011, 480 p. [In Russian]
10. Kristensen S. D., Laut K. G., Fajadet J., Kaifoszova Z. European Heart Journal. 2014, no. 35, pp. 1957–1970.
11. Huber K. European Heart Journal. 2012, no. 33, pp. 1184–1186.
12. Dorofeykov V. V., Sitnikova M. Yu., Lelyavina T. A., Paskar' N. S., Sukhova I. V., Fedotov P. A., Ivanov V. I., Kunina O. I., Shabanova G. R. Mozgovoy natriyureticheskiy peptid v kardiologii i kardiokhirurgii. Meditsinskiy alfavit [Cerebral natriuretic peptide in cardiology and cardiosurgery]. 2014, no. 3, pp. 49–56. [In Russian]
13. Obshchestvo spetsialistov po serdechnoy nedostatochnosti. Rossiyskoe kardiologicheskoe obshchestvo. Klinicheskie rekomendatsii. Khronicheskaya serdechnaya nedostatochnost' [The Society of Specialists in Heart Failure. The Russian Cardiological Society. Clinical guidelines. Chronic Heart Failure]. Moscow, 2016, 92 p. [In Russian]
14. Skvortsov A. A., Koshkina D. E., Protasov V. N., Narusov O. Yu., Masenko V. P., Tereshchenko S. N. Serdechnaya nedostatochnost' [Heart Failure]. 2015, no. 4, pp. 204–217. [In Russian]
15. Denktas A. E., V. H. Vernon Anderson, McCarthy J. et al. JACC: Cardiovascular Interventions. 2011, vol. 4 (6), pp. 599–604.
16. Vnezapnaya serdechnaya smert' [Sudden cardiac death]. Eds. E. V. Shlyakhto, G. P. Arutyunov, Yu. N. Be-lenkov, A. V. Ardashev. Moscow: Medpraktika-M, 2015, 704 p. [In Russian]

 

Дата создания: 06.09.2019 13:18
Дата обновления: 16.09.2019 08:16